Evolving Impact of COVID‐19 on Intestinal Transplant Recipients: A Single‐Center Experience
Our data suggested a possible increase in the incidence of COVID-19 in ITx and MVTx recipients with an unchanged mortality rate despite the use of vaccines and new therapeutic modalities. Further multicenter studies are needed to analyze the real impact of COVID-19 on this unique population.
Authors
- Jennifer Joyce
- William Stein (ORCID: https://orcid.org/0000-0003-2229-7389)
- Ruy J. Cruz (ORCID: https://orcid.org/0000-0001-5290-9978)
- Khanna (ORCID: https://orcid.org/0000-0003-3330-0440)
- Vikraman Gunabushanam (ORCID: https://orcid.org/0000-0003-0974-7904)
- Brielle Corrente
- Colin Powers (ORCID: https://orcid.org/0000-0001-7960-9940)
- F. Silveira
- Shelly Polydor
Institutions
- University of Pittsburgh (US)
- University of Pittsburgh Medical Center (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1111/ctr.70065
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00